1.Anon (2016) Vaccines for postexposure prophylaxis against varicella (chickenpox) in children and adults. Paediatrics & Child Health 21, 91.
2.Simpson, RH (1952) Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 260, 549–554.
3.Ali, A et al. (2003) Decline in annual incidence of varicella-selected states, 1990–2001. JAMA 290, 2250–2250.
4.Streng, A et al. (2013) Varicella routine vaccination and the effects on varicella epidemiology – results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infectious Diseases 13, 303.
5.Lian Ie, B et al. (2011) The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy. Vaccine 29, 1448–1454.
6.Korea Centers for Disease Control and Prevention National Notifiable Disease Surveillance System. http://www.cdc.go.kr/npt/ ( 28 July 2017).
7.Choe, YJ et al. (2013) Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. Journal of Korean Medical Science 28, 1283–1288.
8.Verdecchia, A et al. (1994) An age and period reconstruction of the HIV epidemic in Italy. International Journal of Epidemiology 23, 1027–1039.
9.Préziosi, M-P et al. (2002) Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program. American Journal of Epidemiology 155, 891–896.
10.Kongsomboon, K et al. (2004) Temporal trends of dengue fever/dengue hemorrhagic fever in Bangkok, Thailand from 1981 to 2000: an age-period-cohort analysis. The Southeast Asian Journal of Tropical Medicine and Public Health 35, 913–917.
11.Houweling, H et al. (1999) An age-period-cohort analysis of 50,875 AIDS cases among injecting drug users in Europe. International Journal of Epidemiology 28, 1141–1148.
12.Clayton, D and Schifflers, E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Statistics in Medicine 6, 469–481.
13.Clayton, D and Schifflers, E (1987) Models for temporal variation in cancer rates. I: age–period and age–cohort models. Statistics in Medicine 6, 449–467.
14.TR, H (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annual Review of Public Health 12, 425–457.
15.Holford, TR (1992) Analysing the temporal effects of age, period and cohort. Statistical Methods in Medical Research 1, 317–337.
16.Rosenberg, PS and Anderson, WF (2011) Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiology, Biomarkers & Prevention 20, 1263.
17.Rosenberg, PS, Check, DP and Anderson, WF (2014) A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiology, Biomarkers & Prevention 23, 2296–2302.
18.Vázquez, M et al. (2001) The effectiveness of the varicella vaccine in clinical practice. The New England Journal of Medicine 344, 955–960.
19.Bonanni, P et al. (2013) Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. The Pediatric Infectious Disease Journal 32, e305–e313.
20.Oh, SH et al. (2014) Varicella and varicella vaccination in South Korea. Clinical and Vaccine Immunology 21, 762–768.
21.Vázquez, M et al. (2004) Effectiveness over time of varicella vaccine. JAMA 291, 851–855.
22.Lopez, AS et al. (2006) One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 117, e1070–e1077.
23.Choi, UY et al. (2016) Seropositivity of varicella zoster virus in vaccinated Korean children and MAV vaccine group. Human Vaccines & Immunotherapeutics 12, 2560–2564.
24.Kim, SH et al. (2010) Seroprevalence rate after one dose of varicella vaccine in infants. Journal of Infection 61, 66–72.
25.Choi, WS et al. (2010) Seroprevalence of varicella-zoster virus in Korea. Journal of Medical Virology 82, 2123–2126.
26.Lee, H, Cho, HK and Kim, K-H (2013) Seroepidemiology of varicella-zoster virus in Korea. Journal of Korean Medical Science 28, 195–199.
27.Lee, YH et al. (2016) Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. Journal of Korean Medical Science 31, 1897–1901.
28.Lee, YH et al. (2019) Effects of one-dose varicella vaccination on disease severity in children during outbreaks in Seoul, Korea. Journal of Korean Medical Science 34, e83.
29.Sadzot-Delvaux, C et al. (2008) Varicella vaccination in Japan, South Korea, and Europe. The Journal of Infectious Diseases 197(suppl. 2), S185–S190.
30.Choung, JM et al. (2002) Study on vaccination state in children: Jeonbuk province, 2000. Korean Journal of Pediatrics 45, 1234–1240.
31.Park, S and Cho, E (2014) National infectious diseases surveillance data of South Korea. Epidemiology and Health 36, e2014030.
32.Kim, J-H and Cheong, H-K (2018) Increasing number of scarlet fever cases, South Korea, 2011–2016. Emerging Infectious Diseases 24, 172.